title: Testosterone serum levels and prostate cancer prognosis: the double face of Janus.
authors.affiliation: Department of Medical & Surgical Specialties, Radiological Sciences & Public Health, Medical Oncology, University of Brescia, Spedali Civili Hospital, Piazzale Spedali Civili 1, 25123 Brescia, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Valcamonico
authors.forename: Laura
authors.initials: L
authors.lastname: Ferrari
authors.forename: Francesca
authors.initials: F
authors.lastname: Consoli
authors.forename: Vito
authors.initials: V
authors.lastname: Amoroso
authors.forename: Alfredo
authors.initials: A
authors.lastname: Berruti
mesh_terms: D000728:Androgens / Q000097:blood*; D000730:Androstadienes / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D011241:Prednisone / Q000008:administration & dosage*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000401:mortality*
chemical_list: D000728:Androgens; D000730:Androstadienes; D011241:Prednisone
keywords: castrate-resistant disease; prognosis; prostate cancer; testosterone serum levels